What smart money is saying about Prestige Consumer Healthcare Inc.
2 funds in our archive have pitched Prestige Consumer Healthcare Inc., most recently Riverwater Partners Small Cap Strategy in September 2026.
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Get an email when a fund buys, sells or pitches it
Position history
Between Q2 2026 and Q3 2026, 6 fund letters reported a position in Prestige Consumer Healthcare Inc., with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 1 | 0 | 2 |
| Q2 2026 | 4 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 6 positions · 1 move
- September 2026
“Investments in health care, specifically LENSAR, Grifols, and Prestige Consumer Health, also declined.”
Prestige Consumer Healthcare Inc. - New positionRiverwater Partners Small Cap StrategySeptember 2026
“Prestige Consumer Healthcare (PBH): We initiated a position in Prestige Consumer Healthcare, which owns a portfolio of niche over-the-counter health brands, including Dramamine, Clear Eyes, Breathe Right, and Chloraseptic.”
Prestige Consumer Healthcare Inc. - June 2026
Listed in Ariel Investments Small Cap Value Strategy’s reported holdings.
Prestige Consumer Healthcare Inc. - June 2026
“In pharmaceuticals, Prestige Consumer Healthcare underperformed due to ongoing disruptions in its Clear Eyes product line, stemming from a slower-than-expected recovery in manufacturing operations at a facility.”
Prestige Consumer Healthcare Inc. - June 2026
“Selected health care holdings also declined, specifically Prestige Consumer Health and blood plasma business Grifols.”
Prestige Consumer Healthcare Inc. - June 2026
“Shares of Prestige Consumer Healthcare (PBH) moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.”
Prestige Consumer Healthcare Inc.
Fund coverage · 2 theses
- Riverwater Partners Small Cap StrategySeptember 2026
Prestige Consumer Healthcare is a self-help story with niche OTC brands, high margins and strong free cash flow, a new management turnaround plan, and shares at their lowest valuation in a decade.
Read the full thesis - Tributary Capital Management Small/Mid Cap StrategySeptember 2026
Prestige Consumer Healthcare owns leading OTC brands with pricing power, strong free cash flow, and a capital-light model that supports growth and buybacks.
Read the full thesis
Read every full thesis on Prestige Consumer Healthcare Inc.
Read all 2 theses in full, with each fund's reasoning, and get unlimited access to the archive.
View plans→